allantoin 0.01 MG/MG / benzocaine 0.2 MG/MG / camphor 0.03 MG/MG / petrolatum 0.649 MG/MG [Anbesol Cold Sore Therapy]

RxCUI: 1052618
RxNorm name: allantoin 0.01 MG/MG / benzocaine 0.2 MG/MG / camphor 0.03 MG/MG / petrolatum 0.649 MG/MG [Anbesol Cold Sore Therapy]
Term type: SBDC
Status: Active
Updated: 2026-06-05 07:08:07

RxNorm Status History#

Status: Active
Source: RXNORM
Current: YES
Release start: 022011
Active start: 022011
Multiple ingredient: YES
Branded: YES

Ingredients And Strength#

Ingredient, Strength, Base table
Ingredient	Strength	Base	Basis of strength
	0.2 MG / 1 MG	benzocaine
	0.03 MG / 1 MG	camphor
	0.01 MG / 1 MG	allantoin
	0.649 MG / 1 MG	petrolatum

Derived Ingredient Concepts#

Ingredient, RxCUI table
Ingredient	RxCUI
benzocaine	1399
camphor	1952
allantoin	508
petrolatum	8091

Source Vocabulary Codes#

Code type, Value, Category table
Code type	Value	Category
PRESCRIBABLE	Y	ATTRIBUTES
RXNAV_STR	allantoin 0.01 MG/MG / benzocaine 0.2 MG/MG / camphor 0.03 MG/MG / petrolatum 0.649 MG/MG [Anbesol Cold Sore Therapy]	NAMES
RxNorm Name	allantoin 0.01 MG/MG / benzocaine 0.2 MG/MG / camphor 0.03 MG/MG / petrolatum 0.649 MG/MG [Anbesol Cold Sore Therapy]	NAMES
TTY	SBDC	ATTRIBUTES
RxCUI	1052618	CODES

Drug Classes#

Source, Class ID, Class table
Source	Class ID	Class	Type	Relationship	Drug concept
ATC	D04AB	Anesthetics for topical use	ATC1-4		benzocaine
ATC	R02AD	Anesthetics, local	ATC1-4		benzocaine
ATC	N01BA	Esters of aminobenzoic acid	ATC1-4		benzocaine
ATC	C05AD	Local anesthetics	ATC1-4		benzocaine
FDASPL	N0000185508	Standardized Chemical Allergen	EPC	has_epc	benzocaine
FDASPL	N0000184306	Cell-mediated Immunity	PE	has_pe	benzocaine
FDASPL	N0000175629	Increased Histamine Release	PE	has_pe	benzocaine
MEDRT	D000481	Allantoin	CHEM	has_ingredient	allantoin
MEDRT	D001566	Benzocaine	CHEM	has_ingredient	benzocaine
MEDRT	D002164	Camphor	CHEM	has_ingredient	camphor
MEDRT	D010577	Petrolatum	CHEM	has_ingredient	petrolatum
MEDRT	D001424	Bacterial Infections	DISEASE	ci_with	benzocaine
MEDRT	D002056	Burns	DISEASE	may_treat	benzocaine
MEDRT	D004342	Drug Hypersensitivity	DISEASE	ci_with	benzocaine
MEDRT	D004342	Drug Hypersensitivity	DISEASE	ci_with	camphor
MEDRT	D004433	Earache	DISEASE	may_treat	benzocaine
MEDRT	D005401	Fissure in Ano	DISEASE	may_treat	benzocaine
MEDRT	D006484	Hemorrhoids	DISEASE	may_treat	benzocaine
MEDRT	D006561	Herpes Simplex	DISEASE	may_treat	benzocaine
MEDRT	D019226	Oral Ulcer	DISEASE	may_treat	benzocaine
MEDRT	D010032	Otitis Externa	DISEASE	may_treat	benzocaine
MEDRT	D010033	Otitis Media	DISEASE	may_treat	benzocaine
MEDRT	D010146	Pain	DISEASE	may_prevent	benzocaine
MEDRT	D010146	Pain	DISEASE	may_prevent	camphor
MEDRT	D010146	Pain	DISEASE	may_treat	camphor
MEDRT	D011537	Pruritus	DISEASE	may_treat	benzocaine
MEDRT	D012868	Skin Abnormalities	DISEASE	may_treat	allantoin
MEDRT	D014076	Tooth Diseases	DISEASE	may_treat	camphor
MEDRT	D014098	Toothache	DISEASE	may_treat	benzocaine
MEDRT	D014947	Wounds and Injuries	DISEASE	may_treat	allantoin
MEDRT	N0000000180	Sodium Channel Interactions	MOA	has_moa	benzocaine
MEDRT	N0000009915	Unknown Cellular or Molecular Interaction	MOA	has_moa	camphor
MEDRT	N0000008889	Decreased Sensory-Somatic Nervous System Organized Electrical Activity	PE	has_pe	camphor
MEDRT	N0000008889	Decreased Sensory-Somatic Nervous System Organized Electrical Activity	PE	has_pe	benzocaine
MEDRT	N0000009735	Decreased Skin Keratinization	PE	has_pe	allantoin

Group, Type, Concept table
Group	Type	Concept	Source
BN	BN	Anbesol Cold Sore Therapy	rxnav_allrelated
DF	DF	Topical Ointment	rxnav_allrelated
DFG	DFG	Topical Product	rxnav_allrelated
IN	IN	allantoin	rxnav_allrelated
IN	IN	benzocaine	rxnav_allrelated
IN	IN	camphor	rxnav_allrelated
IN	IN	petrolatum	rxnav_allrelated
MIN	MIN	allantoin / benzocaine / camphor / petrolatum	rxnav_allrelated
SBD	SBD	allantoin 0.01 MG/MG / benzocaine 0.2 MG/MG / camphor 0.03 MG/MG / petrolatum 0.649 MG/MG Topical Ointment [Anbesol Cold Sore Therapy]	rxnav_allrelated
SBDC	SBDC	allantoin 0.01 MG/MG / benzocaine 0.2 MG/MG / camphor 0.03 MG/MG / petrolatum 0.649 MG/MG [Anbesol Cold Sore Therapy]	rxnav_allrelated
SBDF	SBDF	allantoin / benzocaine / camphor / petrolatum Topical Ointment [Anbesol Cold Sore Therapy]	rxnav_allrelated
SBDG	SBDG	Anbesol Cold Sore Therapy Topical Product	rxnav_allrelated
SCD	SCD	allantoin 0.01 MG/MG / benzocaine 0.2 MG/MG / camphor 0.03 MG/MG / petrolatum 0.649 MG/MG Topical Ointment	rxnav_allrelated
SCDC	SCDC	allantoin 0.01 MG/MG	rxnav_allrelated
SCDC	SCDC	benzocaine 0.2 MG/MG	rxnav_allrelated
SCDC	SCDC	camphor 0.03 MG/MG	rxnav_allrelated
SCDC	SCDC	petrolatum 0.649 MG/MG	rxnav_allrelated
SCDF	SCDF	allantoin / benzocaine / camphor / petrolatum Topical Ointment	rxnav_allrelated
SCDG	SCDG	allantoin / benzocaine / camphor / petrolatum Topical Product	rxnav_allrelated

Properties#

Category, Property, Value table
Category	Property	Value
ATTRIBUTES	GENERAL_CARDINALITY	MULTI
ATTRIBUTES	PRESCRIBABLE	Y
ATTRIBUTES	RXNAV_HUMAN_DRUG	US
ATTRIBUTES	TTY	SBDC
CODES	RxCUI	1052618
NAMES	RXNAV_STR	allantoin 0.01 MG/MG / benzocaine 0.2 MG/MG / camphor 0.03 MG/MG / petrolatum 0.649 MG/MG [Anbesol Cold Sore Therapy]
NAMES	RxNorm Name	allantoin 0.01 MG/MG / benzocaine 0.2 MG/MG / camphor 0.03 MG/MG / petrolatum 0.649 MG/MG [Anbesol Cold Sore Therapy]

allantoin 0.01 MG/MG / benzocaine 0.2 MG/MG / camphor 0.03 MG/MG / petrolatum 0.649 MG/MG [Anbesol Cold Sore Therapy]

RxNorm Status History#

Ingredients And Strength#

Derived Ingredient Concepts#

Source Vocabulary Codes#

Drug Classes#

Related Concepts#

Properties#